We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

13 hedge funds and large institutions have $227K invested in Tonix Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% more ownership

Funds ownership: 0% → 0.05% (+0.04%)

46% less funds holding

Funds holding: 24 → 13 (-11)

79% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 14

90% less capital invested

Capital invested by funds: $2.24M → $227K (-$2.01M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
-11
Holders Change %
-45.83%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
7
Reduced
–
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Prudential Financial
Prudential Financial
New Jersey
+$424K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$215K
3
HF
HRT Financial
New York
+$97.6K
4
Jane Street
Jane Street
New York
+$48.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$39.9K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$911K
2
Marshall Wace
Marshall Wace
United Kingdom
-$309K
3
AC
Armistice Capital
New York
-$91K
4
Renaissance Technologies
Renaissance Technologies
New York
-$23K
5
Millennium Management
Millennium Management
New York
-$21.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
26
Armistice Capital
New York
– -$91K -153 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$23K -39 Closed
Millennium Management
28
Millennium Management
New York
– -$21.2K -36 Closed
HWA
29
HCR Wealth Advisors
California
– -$18.6K -31 Closed
Northern Trust
30
Northern Trust
Illinois
– -$17.2K -29 Closed
XT
31
XTX Topco
Cayman Islands
– -$13.4K -23 Closed
State Street
32
State Street
Massachusetts
– -$5.8K -10 Closed
Commonwealth Equity Services
33
Commonwealth Equity Services
Massachusetts
– -$4K -7 Closed
VF
34
Virtu Financial
New York
– -$4K -7 Closed
BIA
35
Barry Investment Advisors
Massachusetts
– -$2.48K -4 Closed
CCM
36
Crew Capital Management
Ohio
– -$1.86K -3 Closed
FWTB
37
First Western Trust Bank
Colorado
– -$1.92K -3 Closed
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$5 – –
NSIM
39
North Star Investment Management
Illinois
– -$1 – –
Osaic Holdings
40
Osaic Holdings
Arizona
– -$6 – –
PA
41
Parallel Advisors
California
– -$88 – –
TCM
42
Tradewinds Capital Management
Washington
– -$1 – –
Wells Fargo
43
Wells Fargo
California
– -$85 – –
1
2

TNXP Hedge Fund Activity: Q2 2024 in Review

13 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2024, worth a combined $227K — down 90% from $2.24M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TNXP and 3 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 7 added.

The largest buyer was Prudential Financial, adding an estimated $424K. The largest seller was Sabby Management, exiting entirely with an estimated $911K sold.

  • 13 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2024, down from 24 in Q1 2024.
  • Funds reported $227K of Tonix Pharmaceuticals stock for Q2 2024, down 90% quarter-over-quarter.
  • 3 funds opened new Tonix Pharmaceuticals positions in Q2 2024 and 14 closed out, a net change of -11 holders.
  • The largest Tonix Pharmaceuticals buyer in Q2 2024 was Prudential Financial, an estimated $424K added.
  • The largest Tonix Pharmaceuticals seller in Q2 2024 was Sabby Management, an estimated $911K sold.

Based on aggregated 13F filings for Q2 2024.